Professor Gilbert R Thompson (1932-2026): Pioneer Who Proved High Cholesterol Causes Heart Disease

The telephone rang in Gilbert Thompson’s office at Hammersmith Hospital in the 1970s. Another colleague calling to challenge his radical theory that cholesterol directly caused heart attacks. The medical establishment believed clogged arteries were simply what happened when you got older – nothing more than natural wear and tear.

But Thompson wasn’t backing down.

Fighting the Medical Establishment

Professor Gilbert R Thompson, who died in 2026 at age 94, spent decades proving what doctors now take for granted. His research at Imperial College London demonstrated that high LDL cholesterol – the so-called “bad” cholesterol – directly causes atherosclerosis, the narrowing of arteries that leads to coronary heart disease.

The opposition was fierce. Medical textbooks taught that blocked arteries were an inevitable part of ageing, like grey hair or wrinkles. Thompson’s hypothesis – that a specific substance in the blood was actively damaging arteries – challenged everything doctors thought they knew.

Yet the evidence kept mounting. The Framingham Heart Study revealed that risk of coronary heart disease under age 50 rises five-fold even within normal cholesterol limits. Natural ageing couldn’t explain why relatively young people were having heart attacks.

The Breakthrough Research

Thompson’s work built methodically on epidemiological evidence. Each study added another piece to the puzzle, showing LDL cholesterol wasn’t just associated with heart disease – it was causing it.

His book “Resolving the Cholesterol Controversy” detailed the painstaking science behind what became known as the lipid hypothesis of atherosclerosis causation. But books weren’t enough to convince sceptics.

The real vindication came through statin trials. Thompson contributed to vital meta-analyses in 2005 that confirmed the lipid hypothesis beyond doubt. These cholesterol-lowering drugs didn’t just reduce numbers on a blood test – they prevented heart attacks and saved lives.

For their part, the Heart Protection Study, linked to Imperial College research, showed statin efficacy worked regardless of baseline HDL levels. The mechanism was clear: lower the LDL cholesterol, reduce the arterial damage, prevent the heart attack.

A Legacy in Every Prescription

Today, lipidology – the field Thompson helped establish – guides treatment for millions. HEART UK, the cholesterol charity, credits researchers like Thompson with settling decades of debate through rigorous trials proving LDL’s direct role in heart disease.

The transformation has been remarkable. What was once controversial is now standard care, with statins among the most prescribed medications worldwide.

Key Takeaways

• Professor Gilbert R Thompson proved high LDL cholesterol directly causes atherosclerosis, overcoming fierce medical opposition
• His research at Imperial College London helped establish lipidology as a medical specialty and validated statin therapy
• The Framingham Heart Study showed heart disease risk rises five-fold under age 50 even within normal cholesterol ranges

What This Means for Kent Residents

Kent residents benefit directly from Thompson’s pioneering research through NHS Kent and Medway ICB cardiovascular services that follow national lipidology guidelines. Local GP practices across Kent apply NICE guidelines on statins for high cholesterol, chiefly important in high-prevalence areas like Medway where heart disease rates remain elevated. Residents can access cholesterol testing through NHS health checks at Kent pharmacies or GP surgeries – a routine service that exists because Thompson proved these numbers matter for preventing heart attacks, not just measuring them.